1. Home
  2. MTEK vs ADVB Comparison

MTEK vs ADVB Comparison

Compare MTEK & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$1.15

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$4.41

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEK
ADVB
Founded
2008
2014
Country
Israel
United States
Employees
14
31
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MTEK
ADVB
Price
$1.15
$4.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
104.3K
78.1K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.19
52 Week High
$4.27
$7.70

Technical Indicators

Market Signals
Indicator
MTEK
ADVB
Relative Strength Index (RSI) 38.20 41.73
Support Level $1.08 $4.08
Resistance Level $1.50 $5.71
Average True Range (ATR) 0.13 0.83
MACD 0.00 -0.23
Stochastic Oscillator 21.22 2.12

Price Performance

Historical Comparison
MTEK
ADVB

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: